
Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…

Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…
Location & focus: Boston-based diagnostics company focused on WGS-based cellular liquid biopsy for multiple myeloma and plasma cell dyscrasias
Flagship product: GenoPredicta — whole-genome sequencing-based clinical assay for blood and bone marrow
Use cases: Noninvasive disease monitoring, treatment decision support for immunotherapies, and discovery of immunotherapy targets
Founding year: 2023
Recent funding: Series A (Oct 2025); reported round about $23.4M; total funding reported ~$28.6M
Diagnostics and monitoring for hematologic cancers (multiple myeloma and plasma cell dyscrasias); precision oncology and immunotherapy target discovery.
2023
Biotechnology Research
23,400,000
Dealroom reports Series A amount $23.4M; Crunchbase lists Engine Ventures as lead
“Backed by life-sciences and strategic investors including Engine Ventures, Illumina Ventures, Mass General Brigham Ventures, Binney Street Capital and others”
| Company |
|---|
Company Description
Predicta Biosciences is a precision oncology company at the forefront of integrating multiomics and liquid biopsy technologies to advance cancer diagnosis and treatment. Its innovative diagnostic products eliminate the need for bone-marrow biopsies by using blood-based samples, enabling more precise treatment decisions for immunotherapies. Additionally, Predicta's proprietary platform supports the discovery and development of novel immunotherapy targets within its therapeutic pipeline. The company’s mission is to improve patient outcomes through cutting-edge precision medicine.
Position Summary
The Client Support Specialist is responsible for ensuring that all required patient, physician, and billing information associated with genomic testing orders is accurately collected, documented, and maintained within the NetSuite system.
This role serves as a key liaison between patients, physician offices, billing teams, and internal clinical laboratory staff to ensure that all necessary documentation, samples, and authorizations are received so genomic testing orders can proceed through the laboratory workflow.
In addition, this position will serve to assist in other matters such as quality assurance, operations and development of standard operating procedures.
Key Responsibilities
Qualifications
Required
Preferred
Work Location
This role is based in Cambridge Massachusetts and can be a hybrid role.
Why Join Predicta Biosciences?
This is a unique opportunity to be part of a mission-driven team advancing precision diagnostics for hematologic cancers. You’ll play a key role in shaping the quality and performance of our clinical testing efforts and contribute directly to patient-impactful innovations.
The annual salary range for this position is $75,000-95,000 plus a 10% bonus opportunity. Predicta considers a variety of factors when determining base compensation, including experience, skills, education, qualifications, and geographic location. Actual compensation will vary, and it is not typical to be hired at or near the top of the range for the role. Additional rewards include equity, flexible time off, 401k Plan, medical, dental and vision plans that are 90% paid by Predicta and a partially company funded HSA.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week